About

Name

Glen Baker
University

University of Alberta
Website

psychiatry.med.ualberta.ca/AboutUs/DepartmentMembers/Academic/Baker.aspx
Email

[email protected]
Research Keywords

biomarkers in psychiatric and neurological disorders, neurochemistry of depression, schizophrenia and anxiety disorders, drug metabolism and drug interactions, neuroprotective drugs

Additional Information

Lab Methodologies
  • Neurosteroid Assays
  • Amino acid detection
  • Biogenic amines and metabolites including trace amines
  • Radiochemical lab
Apparatus
  • HPLC (fluorimetry, electrochemical, UV detection)
  • HPLC Mass Spectrometry
  • Gas Chromatography Electron Capture detector
  • Gas Chromatography Mass Spectrometry including Triple Quad
  • Liquid Scintillation Counter

 

Roles and Connections

Primary Role

Faculty
CAN Connections

Depression

Most Cited Publications

Matveychuk D, MacKenzie EM, Kumpula D, Song MS, Holt A, Kar S, Todd KG, Wood PL, Baker GB, "Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine." Cellular and molecular neurobiology 42,1 (2022 Jan): 225-242
MacKay MB, Paylor JW, Wong JTF, Winship IR, Baker GB, Dursun SM, "Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics." Frontiers in psychiatry 9, (2018): 537
Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, Dursun SM, "Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers." Therapeutic advances in psychopharmacology 10, (2020): 2045125320916657